Dow Up 0.12% Nasdaq Up 1.35%

Poniard Pharmaceuticals, Inc. (PARD)

-Other OTC
0.20 0.05(20.00%) Oct 20, 1:30PM EDT
|Pre-Market : 2.14 0.00 (0.00%) 4:00PM EST - Nasdaq Real Time Price
Prev Close:0.25
Open:0.15
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:2.07
Next Earnings Date:N/A
Day's Range:0.15 - 0.20
52wk Range:0.15 - 0.56
Volume:2,798
Avg Vol (3m):1,963
Market Cap:299.80K
P/E (ttm):N/A
EPS (ttm):-3.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PARDDown 20.00%299.80K
BMY83.82B
IMGN812.68M
SNY135.88B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-11) :N/A
Quarterly EPS Est (Mar-11) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback